@article{ATM22212,
author = {George Zarkavelis and George Pentheroudakis},
title = {TAILORing targeted therapies to the right patient at the right time: how close are we?},
journal = {Annals of Translational Medicine},
volume = {6},
number = {Suppl 1},
year = {2018},
keywords = {},
abstract = {The therapeutic landscape of metastatic colorectal cancer has dramatically evolved over the last decade leading to improved survival outcomes. Patients can now achieve median survival times in excess of 2 years with the use of targeted therapies that have become an integral part of colon cancer therapeutics (1).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/22212}
}